| Year |
Title |
Altmetric |
| 2021
|
Coronavirus Disease 2019-Associated Invasive Fungal Infection.
Open Forum Infectious Diseases.
8.
2021
|
|
| 2021
|
Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial.
Clinical Infectious Diseases.
73:E3647-E3655.
2021
|
|
| 2021
|
MSG07: An International Cohort Study Comparing Epidemiology and Outcomes of Patients with Cryptococcus neoformans or Cryptococcus gattii Infections.
Clinical Infectious Diseases.
73:1133-1141.
2021
|
|
| 2021
|
Antifungal Pipeline.
Frontiers in Cellular and Infection Microbiology.
11.
2021
|
|
| 2021
|
COVID-19-Lessons Learned and Questions Remaining.
Clinical Infectious Diseases.
72:2225-2240.
2021
|
|
| 2021
|
Candidemia and Invasive Candidiasis.
Infectious Disease Clinics of North America.
35:389-413.
2021
|
|
| 2021
|
Cryptococcal Antigen in Serum and Cerebrospinal Fluid for Detecting Cryptococcal Meningitis in Adults Living with Human Immunodeficiency Virus: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies.
Clinical Infectious Diseases.
72:1268-1278.
2021
|
|
| 2021
|
The Evidence Supporting the Revised EORTC/MSGERC Definitions for Invasive Fungal Infections.
Clinical Infectious Diseases.
72:S77-S78.
2021
|
|
| 2021
|
Reply to simon and to eljaaly and nix.
Clinical Infectious Diseases.
63:287-288.
2021
|
|
| 2020
|
Reply to Luppi et al.
Clinical Infectious Diseases.
71:3266.
2020
|
|
| 2020
|
Reply to Herbrecht et al.
Clinical Infectious Diseases.
71:2774-2775.
2020
|
|
| 2020
|
Reply to Mafaciolli and Pasqualotto.
Clinical Infectious Diseases.
71:2542-2543.
2020
|
|
| 2020
|
Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium.
Clinical Infectious Diseases.
71:1367-1376.
2020
|
|
| 2020
|
Invasive aspergillosis as an under-recognized superinfection in COVID-19.
Open Forum Infectious Diseases.
7.
2020
|
|
| 2020
|
Long-term Outcomes of Patients with Fungal Infections Associated with Contaminated Methylprednisolone Injections.
Open Forum Infectious Diseases.
7.
2020
|
|
| 2020
|
Reply to Tascini et al.
Clinical Infectious Diseases.
70:1523-1524.
2020
|
|
| 2020
|
Histoplasmosis: Time to Redraw the Map and Up Our Game.
Clinical Infectious Diseases.
70:1011-1013.
2020
|
|
| 2020
|
A multicenter, longitudinal cohort study of cryptococcosis in human immunodeficiency virus-negative people in the United States.
Clinical Infectious Diseases.
70:252-261.
2020
|
|
| 2020
|
Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium.
Journal of Infectious Diseases.
222:S175-S198.
2020
|
|
| 2019
|
Clinical mycology today: A synopsis of the mycoses study group education and research consortium (MSGERC) second biennial meeting, September 27-30, 2018, Big Sky, Montana, a proposed global research agenda.
Medical Mycology.
58:569-578.
2019
|
|
| 2019
|
MSG-10: A Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis.
Journal of Antimicrobial Chemotherapy.
74:3056-3062.
2019
|
|
| 2019
|
Performance of the T2bacteria panel for diagnosing bloodstream infections.
ACP journal club.
170:845-852.
2019
|
|
| 2019
|
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.
Clinical Infectious Diseases.
68:1981-1989.
2019
|
|
| 2019
|
Impact of infectious disease consultation on clinical management and mortality in patients with candidemia.
Clinical Infectious Diseases.
68:1585-1587.
2019
|
|
| 2019
|
Amphotericin B induction with voriconazole consolidation as salvage therapy for FKS-associated echinocandin resistance in Candida glabrata septic arthritis and osteomyelitis.
Antimicrobial Agents and Chemotherapy.
63.
2019
|
|
| 2018
|
Improvement of gram-negative susceptibility to fluoroquinolones after implementation of a pre-authorization policy for fluoroquinolone use: A decade-long experience.
Infection Control and Hospital Epidemiology.
39:1419-1424.
2018
|
|
| 2018
|
Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi-year, multicenter prospective cohort study.
Transplant Infectious Disease.
20.
2018
|
|
| 2018
|
Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: Analysis of trends and outcomes.
Journal of Antimicrobial Chemotherapy.
73:1677-1680.
2018
|
|
| 2018
|
Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel.
Clinical Infectious Diseases.
66:1678-1686.
2018
|
|
| 2018
|
Invasive candidiasis.
Nature Reviews Disease Primers.
4.
2018
|
|
| 2018
|
Efficacy of T2 magnetic resonance assay in monitoring candidemia after initiation of antifungal therapy: The serial therapeutic and antifungal monitoring protocol (STAMP) trial.
Journal of Clinical Microbiology.
56.
2018
|
|
| 2018
|
Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients.
Transplant Infectious Disease.
20.
2018
|
|
| 2018
|
Management of an Outbreak of Exophiala dermatitidis Bloodstream Infections at an Outpatient Oncology Clinic.
Clinical Infectious Diseases.
66:959-962.
2018
|
|
| 2018
|
Antibody and B cell subset perturbations in human immunodeficiency virus-uninfected patients with cryptococcosis.
Open Forum Infectious Diseases.
5.
2018
|
|
| 2017
|
Thinking beyond the common Candida species: Need for species-level identification of Candida due to the emergence of multidrug-resistant Candida auris.
Journal of Clinical Microbiology.
55:3324-3327.
2017
|
|
| 2017
|
In Memorium: William Ernest Dismukes 1939-2017..
Journal of Infectious Diseases.
2017
|
|
| 2017
|
Late-onset cerebral toxoplasmosis after allogeneic hematopoietic stem cell transplantation.
Case Reports and Clinical Practice Review.
18:246-250.
2017
|
|
| 2017
|
Infections in hematopoietic cell transplant recipients: Results from the organ transplant infection project, a multicenter, prospective, cohort study.
Open Forum Infectious Diseases.
4.
2017
|
|
| 2017
|
A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases.
Open Forum Infectious Diseases.
4.
2017
|
|
| 2017
|
The case for adopting the "species complex" nomenclature for the etiologic agents of cryptococcosis.
Clinical and Vaccine Immunology.
2.
2017
|
|
| 2016
|
Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: A retrospective observational cohort study of the Mycoses Study Group (MSG-12).
Journal of Antimicrobial Chemotherapy.
71:3536-3539.
2016
|
|
| 2016
|
The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
Transplant Infectious Disease.
18:921-931.
2016
|
|
| 2016
|
Isavuconazole treatment for mucormycosis: A single-arm open-label trial and case-control analysis.
Lancet Infectious Diseases.
16:828-837.
2016
|
|
| 2016
|
Cryptococcal osteomyelitis: A report of 5 cases and a review of the recent literature
2016
|
|
| 2016
|
Invasive Candidiasis.
Infectious Disease Clinics of North America.
30:103-124.
2016
|
|
| 2016
|
Comparison between liposomal formulations of amphotericin B.
Medical Mycology.
54:223-231.
2016
|
|
| 2016
|
Acute cryptococcal immune reconstitution inflammatory syndrome in a patient on natalizumab.
Open Forum Infectious Diseases.
3.
2016
|
|
| 2015
|
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.
Clinical Infectious Diseases.
62:e1-e50.
2015
|
|
| 2015
|
Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.
Clinical Infectious Diseases.
62:409-417.
2015
|
|
| 2015
|
Update on multistate outbreak of fungal infections associated with contaminated methylprednisolone injections, 2012-2014
2015
|
|
| 2015
|
A paradoxical decline: Intracranial lesions in two HIV-positive patients recovering from cryptococcal meningitis.
BMJ Case Reports.
2015.
2015
|
|
| 2015
|
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison with Antigen Testing.
Clinical Infectious Diseases.
61:1293-1303.
2015
|
|
| 2015
|
Reply to Bauer and Goff.
Clinical Infectious Diseases.
61:487-488.
2015
|
|
| 2015
|
Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET).
Medical Mycology.
53:440-446.
2015
|
|
| 2015
|
Cytomegalovirus appendicitis in solid organ transplant patients, two cases and a review.
Journal of Clinical Virology.
66:48-50.
2015
|
|
| 2015
|
T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: A clinical trial.
Clinical Infectious Diseases.
60:892-899.
2015
|
|
| 2015
|
Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: A Collaborative Study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group.
Clinical Infectious Diseases.
60:713-720.
2015
|
|
| 2015
|
Combination antifungal therapy for invasive aspergillosis a randomized trial.
ACP journal club.
162:81-89.
2015
|
|
| 2014
|
An expanded role for therapeutic lumbar punctures in newly diagnosed aids-associated cryptococcal meningitis?.
Clinical Infectious Diseases.
59:1615-1617.
2014
|
|
| 2014
|
The Evolving Epidemiology of Sporotrichosis.
Current Fungal Infection Reports.
8:255-261.
2014
|
|
| 2014
|
Reversible blindness in cryptococcal meningitis with normal intracranial pressure: Case report and review of the literature.
Clinical Infectious Diseases.
59:310-313.
2014
|
|
| 2014
|
MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.
Clinical Infectious Diseases.
58:1219-1226.
2014
|
|
| 2014
|
Mortality after clinical management of aids-associated cryptococcal meningitis in Kenya.
East African Medical Journal.
91:145-151.
2014
|
|
| 2014
|
Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.
Transplantation.
97:446-450.
2014
|
|
| 2014
|
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: Results from an open-label trial.
BMC Infectious Diseases.
14.
2014
|
|
| 2014
|
Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species
2014
|
|
| 2014
|
Antifungal clinical trials and guidelines: What we know and do not know.
Cold Spring Harbor Perspectives in Medicine.
4.
2014
|
|
| 2014
|
Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).
Transplant Infectious Disease.
16:213-224.
2014
|
|
| 2014
|
Epidemiology of invasive mold infections in lung transplant recipients.
American Journal of Transplantation.
14:1328-1333.
2014
|
|
| 2014
|
Race and invasive fungal infection in solid organ transplant recipients
2014
|
|
| 2014
|
Target lesions in a neutropenic patient.
Internal and Emergency Medicine.
9:593-595.
2014
|
|
| 2013
|
Lessons learned in the multistate fungal infection outbreak in the United States.
Current Opinion in Infectious Diseases.
26:545-550.
2013
|
|
| 2013
|
Cryptococcal infections: Changing epidemiology and implications for therapy.
Drugs.
73:495-504.
2013
|
|
| 2013
|
Real-time treatment guidelines: Considerations during the Exserohilum rostratum outbreak in the United States.
Antimicrobial Agents and Chemotherapy.
57:1573-1576.
2013
|
|
| 2013
|
Predictors of Mortality and Differences in Clinical Features among Patients with Cryptococcosis According to Immune Status.
PLoS One.
8.
2013
|
|
| 2013
|
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
Medical Mycology.
51:128-135.
2013
|
|
| 2013
|
Cryptococcal infections in non-HIV-infected patients..
Transactions of the American Clinical and Climatological Association.
124:61-79.
2013
|
|
| 2013
|
Fungal infections associated with contaminated methylprednisolone injections.
New England Journal of Medicine.
368:2495-2500.
2013
|
|
| 2013
|
Prototheca wickerhamii algaemia presenting as cholestatic hepatitis in a patient with systemic lupus erythematosus: A case report and literature review.
Medical Mycology Case Reports.
2:19-22.
2013
|
|
| 2012
|
Prevention and treatment of cancer-related infections.
Journal of the National Comprehensive Cancer Network : JNCCN.
10:1412-1445.
2012
|
|
| 2012
|
Pneumocystis pneumonia in hospitalized patients: A detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons.
Transplant Infectious Disease.
14:510-518.
2012
|
|
| 2012
|
Reply to Anaissie and Nucci and to Cisneros et al.
Clinical Infectious Diseases.
55:894-895.
2012
|
|
| 2012
|
Fatal burkholderia gladioli infection misidentified as empedobacter brevis in a lung transplant recipient with cystic fibrosis.
Transplant Infectious Disease.
14.
2012
|
|
| 2012
|
Association between Vancomycin-resistant enterococci bacteremia and ceftriaxone usage.
Infection Control and Hospital Epidemiology.
33:718-724.
2012
|
|
| 2012
|
Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemia.
Antimicrobial Agents and Chemotherapy.
56:3133-3137.
2012
|
|
| 2012
|
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution.
Journal of Clinical Microbiology.
50:2040-2046.
2012
|
|
| 2012
|
Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: A patient-level quantitative review of randomized trials.
Clinical Infectious Diseases.
54:1110-1122.
2012
|
|
| 2012
|
Micafungin for candidiasis
2012
|
|
| 2011
|
Pulmonary cryptococcosis
2011
|
|
| 2011
|
Pulmonary fungal infections
2011
|
|
| 2011
|
Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease
2011
|
|
| 2011
|
Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients.
International Journal of STD and AIDS.
22:665-670.
2011
|
|
| 2011
|
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: A multivariate analysis of factors associated with improved outcome.
BMC Infectious Diseases.
11.
2011
|
|
| 2011
|
Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya
2011
|
|
| 2011
|
In Vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the transplant-associated infection surveillance network.
Antimicrobial Agents and Chemotherapy.
55:3944-3946.
2011
|
|
| 2011
|
Ocular manifestations of candidemia.
Clinical Infectious Diseases.
53:262-268.
2011
|
|
| 2011
|
The role of azoles in the treatment of invasive mycoses: Review of the infectious diseases society of America guidelines.
Current Opinion in Infectious Diseases.
24.
2011
|
|
| 2011
|
Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006.
Journal of Clinical Microbiology.
49:2404-2410.
2011
|
|
| 2011
|
Candidemia in the intensive care unit: Miles to go before we sleep.
Critical Care Medicine.
39:884-885.
2011
|
|
| 2011
|
IAccumulated safety data of micafungin in therapy and prophylaxis in fungal diseases.
Expert Opinion on Drug Safety.
10:171-183.
2011
|
|
| 2011
|
Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit
2011
|
|
| 2011
|
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006
2011
|
|
| 2010
|
The prevalence, clinical features, risk factors and outcome associated with cryptococcal meningitis in HIV positive patients in Kenya.
East African Medical Journal.
87:481-487.
2010
|
|
| 2010
|
Reply to Hoenigl et al.
Clinical Infectious Diseases.
51:254-255.
2010
|
|
| 2010
|
Cryptococcal meningitis: Current approaches to management in patients with and without AIDS.
Current Infectious Disease Reports.
12:299-305.
2010
|
|
| 2010
|
Factors associated with mortality in transplant patients with invasive aspergillosis.
Clinical Infectious Diseases.
50:1559-1567.
2010
|
|
| 2010
|
Cerebral infarction from acquired immunodeficiency syndrome-related cryptococcal meningitis: An overlooked complication of a common opportunistic infection?.
Infectious Diseases in Clinical Practice.
18:198-200.
2010
|
|
| 2010
|
Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (Transnet).
Clinical Infectious Diseases.
50:1101-1111.
2010
|
|
| 2010
|
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: Overview of the transplant- associated infection surveillance network (TRANSNET) database.
Clinical Infectious Diseases.
50:1091-1100.
2010
|
|
| 2010
|
Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.
HIV Medicine.
11:276-281.
2010
|
|
| 2010
|
Blastomycosis of the central nervous system: A multicenter review of diagnosis and treatment in the modern era.
Clinical Infectious Diseases.
50:797-804.
2010
|
|
| 2010
|
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America.
Clinical Infectious Diseases.
50:291-322.
2010
|
|
| 2010
|
Cryptococcosis in the developing world: An elephant in the parlor.
Clinical Infectious Diseases.
50:345-346.
2010
|
|
| 2010
|
International collaboration between US and Thailand on a clinical trial of treatment for HIV-associated cryptococcal meningitis.
Contemporary Clinical Trials.
31:34-43.
2010
|
|
| 2009
|
Candida in solid organ transplant recipients.
American Journal of Transplantation.
9.
2009
|
|
| 2009
|
Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis.
International Journal of Antimicrobial Agents.
34:494-496.
2009
|
|
| 2009
|
Molecular identification of Aspergillus species collected for the transplant-associated infection surveillance network.
Journal of Clinical Microbiology.
47:3138-3141.
2009
|
|
| 2009
|
Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the transplant-associated infection surveillance network.
Journal of Clinical Microbiology.
47:3271-3275.
2009
|
|
| 2009
|
Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: A prospective multicenter study.
Clinical Infectious Diseases.
49:931-934.
2009
|
|
| 2009
|
Reply to kontoyiannis.
Clinical Infectious Diseases.
49:639-640.
2009
|
|
| 2009
|
Cryptococcal disease presenting as necrotizing cellulitis in transplant recipients: Case report.
Transplant Infectious Disease.
11:353-358.
2009
|
|
| 2009
|
A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis.
Clinical Infectious Diseases.
48:1775-1783.
2009
|
|
| 2009
|
Blastomycosis: New Insights into Diagnosis, Prevention, and Treatment.
Clinics in Chest Medicine.
30:227-239.
2009
|
|
| 2009
|
Clinical practice guidelines for the management of candidiasis: 2009 Update by the Infectious Diseases Society of America.
Clinical Infectious Diseases.
48:503-535.
2009
|
|
| 2009
|
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.
AIDS.
23:525-530.
2009
|
|
| 2009
|
Outcomes of antifungal prophylaxis in high-risk liver transplant recipients.
Transplant Infectious Disease.
11:40-48.
2009
|
|
| 2009
|
Risk factors for acquisition of endemic blastomycosis.
Canadian Journal of Infectious Diseases and Medical Microbiology.
20:117-121.
2009
|
|
| 2008
|
Histoplasmosis in HIV-infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapy.
Diagnostic Microbiology and Infectious Disease.
62:151-156.
2008
|
|
| 2008
|
Pulmonary cryptococcosis in patients without HIV infection: Factors associated with disseminated disease
2008
|
|
| 2008
|
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria.
Clinical Infectious Diseases.
47:674-683.
2008
|
|
| 2008
|
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis (Clinical Infectious Diseases (2007) 45, (883-893)).
Clinical Infectious Diseases.
47:302.
2008
|
|
| 2008
|
Clinical practice guidelines for the management of blastomycosis: 2008 Update by the infectious diseases society of America.
Clinical Infectious Diseases.
46:1801-1812.
2008
|
|
| 2008
|
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
Clinical Infectious Diseases.
46:1813-1821.
2008
|
|
| 2008
|
Temporary external lumbar drainage for reducing elevated intracranial pressure in HIV-infected patients with cryptococcal meningitis.
International Journal of STD and AIDS.
19:268-271.
2008
|
|
| 2008
|
Reply to Eiland et al..
Clinical Infectious Diseases.
46:641.
2008
|
|
| 2008
|
Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis.
Infection Control and Hospital Epidemiology.
29:25-30.
2008
|
|
| 2007
|
Clinical practice guidelines for the management of sporotrichosis: 2007 Update by the Infectious Diseases Society of America.
Clinical Infectious Diseases.
45:1255-1265.
2007
|
|
| 2007
|
Combination antifungal therapy for the treatment of invasive yeast and mold infections.
Current Infectious Disease Reports.
9:448-456.
2007
|
|
| 2007
|
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
Clinical Infectious Diseases.
45:883-893.
2007
|
|
| 2007
|
Study of common functional genetic polymorphisms of FCGR2A, 3A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients.
Medical Mycology.
45:513-518.
2007
|
|
| 2007
|
Nonsporulating clinical isolate identified as Petromyces alliaceus (Anamorph Aspergillus alliaceus) by morphological and sequence-based methods.
Journal of Clinical Microbiology.
45:2701-2703.
2007
|
|
| 2007
|
Anidulafungin versus fluconazole for invasive candidiasis.
New England Journal of Medicine.
356:2472-2482.
2007
|
|
| 2007
|
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting
2007
|
|
| 2007
|
Design and methodology of the Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR-ICU) trial [1].
Infection Control and Hospital Epidemiology.
28:245-246.
2007
|
|
| 2006
|
Clinical research in the lay press: Irresponsible journalism raises a huge dose of doubt.
Clinical Infectious Diseases.
43:1031-1039.
2006
|
|
| 2006
|
Invasive Candidiasis.
Infectious Disease Clinics of North America.
20:485-506.
2006
|
|
| 2006
|
Invasive fungal pathogens: Current epidemiological trends.
Clinical Infectious Diseases.
43.
2006
|
|
| 2006
|
Authors' reply [8]
2006
|
|
| 2006
|
Invasive fungal infections in low-risk liver transplant recipients: A multi-center prospective observational study.
American Journal of Transplantation.
6:386-391.
2006
|
|
| 2006
|
Invasive candidiasis in the intensive care unit.
Critical Care Medicine.
34:857-863.
2006
|
|
| 2005
|
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: A randomised non-inferiority trial
2005
|
|
| 2005
|
Activity of posaconazole in the treatment of central nervous system fungal infections.
Journal of Antimicrobial Chemotherapy.
56:745-755.
2005
|
|
| 2005
|
Multicenter clinical evaluation of the (1→3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans.
Clinical Infectious Diseases.
41:654-659.
2005
|
|
| 2005
|
Antifungal combination therapy: Clinical potential.
Drugs.
65:1461-1480.
2005
|
|
| 2005
|
Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: Interim results of a prospective multicenter surveillance program.
Medical Mycology.
43.
2005
|
|
| 2005
|
Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis.
Antimicrobial Agents and Chemotherapy.
49:952-958.
2005
|
|
| 2005
|
Managing cryptococcal meningitis is about handling the pressure.
Clinical Infectious Diseases.
40:480-482.
2005
|
|
| 2004
|
Fungemia caused by Zygoascus hellenicus in an allogeneic stem cell transplant recipient.
Journal of Clinical Microbiology.
42:3363-3365.
2004
|
|
| 2004
|
Recombinant interferon-γ1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis.
Journal of Infectious Diseases.
189:2185-2191.
2004
|
|
| 2004
|
Blastomycosis
2004
|
|
| 2004
|
Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day-1) in the treatment of cutaneous or lymphocutaneous sporotrichosis
2004
|
|
| 2004
|
Surgical treatment of multiple skull abscesses associated with coccidioidomycosis
2004
|
|
| 2004
|
Guidelines for Treatment of Candidiasis.
Clinical Infectious Diseases.
38:161-189.
2004
|
|
| 2004
|
Immunotherapy for invasive fungal infections: From bench to bedside.
Drug Resistance Updates.
7:3-10.
2004
|
|
| 2003
|
Epidemiology of Aspergillus terreus at a University Hospital.
Journal of Clinical Microbiology.
41:5525-5529.
2003
|
|
| 2003
|
Donor-Related Coccidioidomycosis in Organ Transplant Recipients.
Clinical Infectious Diseases.
37:1265-1269.
2003
|
|
| 2003
|
Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.
Antimicrobial Agents and Chemotherapy.
47:3149-3154.
2003
|
|
| 2003
|
A prospective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.
Clinical Infectious Diseases.
37:634-643.
2003
|
|
| 2003
|
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.
Clinical Infectious Diseases.
36:1221-1228.
2003
|
|
| 2003
|
Blastomycosis.
Infectious Disease Clinics of North America.
17:21-40.
2003
|
|
| 2003
|
Current concepts in the management of fungal peritonitis.
Current Infectious Disease Reports.
5:120-124.
2003
|
|
| 2002
|
Blastomycosis: Gilchrist's disease revisited.
Current clinical topics in infectious diseases.
61-77.
2002
|
|
| 2002
|
Fungal brain abscess in transplant recipients: Epidemiologic, microbiologic, and clinical features.
Clinical Transplantation.
16:419-424.
2002
|
|
| 2002
|
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy [1] (multiple letters).
New England Journal of Medicine.
346:1745-1747.
2002
|
|
| 2002
|
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
New England Journal of Medicine.
346:225-234.
2002
|
|
| 2001
|
Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: Maximum tolerated dose study.
Antimicrobial Agents and Chemotherapy.
45:3487-3496.
2001
|
|
| 2001
|
A lawyer from Honduras with fever and hypotension.
Infections in medicine.
18:453-460.
2001
|
|
| 2001
|
The impact of culture isolation of Aspergillus species: A hospital-based survey of aspergillosis.
Clinical Infectious Diseases.
33:1824-1833.
2001
|
|
| 2001
|
Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998.
Antimicrobial Agents and Chemotherapy.
45:3065-3069.
2001
|
|
| 2001
|
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.
Clinical Infectious Diseases.
33:690-699.
2001
|
|
| 2001
|
Therapy of Cryptococcal Meningitis in non-HIV-infected Patients..
Current Infectious Disease Reports.
3:365-370.
2001
|
|
| 2001
|
Invasive mold infections in allogeneic bone marrow transplant recipients.
Clinical Infectious Diseases.
32:1319-1324.
2001
|
|
| 2001
|
Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons.
Clinical Infectious Diseases.
32:1215-1220.
2001
|
|
| 2001
|
Infections in the neutropenic patient--new views of an old problem..
Hematology.
113-139.
2001
|
|
| 2001
|
Reply to Dr. Chandrasekar (Clin Infect Dis 2001; 32: 320-1) and Drs. Marr and Boeckh (Clin Infect Dis 2001; 32: 321) [1].
Clinical Infectious Diseases.
32:518-519.
2001
|
|
| 2001
|
Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a University Hospital.
Diagnostic Microbiology and Infectious Disease.
39:199-201.
2001
|
|
| 2001
|
Viral latency--the papillomavirus model..
Developments in Biologicals.
106.
2001
|
|
| 2000
|
Candiduria: A randomized, double-blind study of treatment with fluconazole and placebo.
Clinical Infectious Diseases.
30:19-24.
2000
|
|
| 2000
|
Sporotrichosis in Peru: Description of an area of hyperendemicity.
Clinical Infectious Diseases.
30:65-70.
2000
|
|
| 2000
|
Microascus cinereus (anamorph Scopulariopsis) brain abscess in a bone marrow transplant recipient.
Journal of Clinical Microbiology.
38:395-397.
2000
|
|
| 2000
|
Fungal infections in ventricular assist devices.
ASAIO Journal.
46.
2000
|
|
| 2000
|
Practice guidelines for the management of cryptococcal disease.
Clinical Infectious Diseases.
30:710-718.
2000
|
|
| 2000
|
Practice guidelines for the management of patients with blastomycosis.
Clinical Infectious Diseases.
30:679-683.
2000
|
|
| 2000
|
Practice guidelines for the treatment of candidiasis.
Clinical Infectious Diseases.
30:662-678.
2000
|
|
| 1999
|
Therapeutic Approach to Candida Sepsis..
Current Infectious Disease Reports.
1:245-252.
1999
|
|
| 1999
|
Liposomal amphotericin b for empirical therapy in patients with persistent fever and neutropenia.
New England Journal of Medicine.
340:764-771.
1999
|
|
| 1999
|
Cryptococcosis: Population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons.
Journal of Infectious Diseases.
179:449-454.
1999
|
|
| 1998
|
Surveillance of cryptococcosis in Alabama, 1992-1994.
Annals of Epidemiology.
8:212-216.
1998
|
|
| 1998
|
Vertebral blastomycosis with paravertebral abscess: Report of eight cases and review of the literature.
Clinical Infectious Diseases.
26:413-418.
1998
|
|
| 1997
|
Cryptococcosis in non-HIV infected patients: A multicemer survey.
Clinical Infectious Diseases.
25:379.
1997
|
|
| 1997
|
Current trends in nosocomial candidemia: Results of a large multienter study.
Clinical Infectious Diseases.
25:357.
1997
|
|
| 1997
|
Blastomycosis in the immunocompromised patient.
Seminars in respiratory infections.
12:243-251.
1997
|
|
| 1997
|
Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome.
American Journal of Medicine.
103:223-232.
1997
|
|
| 1997
|
Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study Group..
Clinical Infectious Diseases.
25:200-205.
1997
|
|
| 1997
|
A randomized, double-blind trial of parenteral low dose versus high dose interferon-β in combination with cryotherapy for treatment of condyloma acuminatum.
Antiviral Research.
35:41-52.
1997
|
|
| 1997
|
Treatment of blastomycosis with higher doses of fluconazole.
Clinical Infectious Diseases.
25:200-205.
1997
|
|
| 1996
|
Fluconazole therapy for histoplasmosis. The National Institute of Allergy and Infectious Diseases Mycoses Study Group..
Clinical Infectious Diseases.
23:996-1001.
1996
|
|
| 1996
|
Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group..
Annals of Internal Medicine.
125:376-383.
1996
|
|
| 1996
|
Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group..
Journal of Clinical Microbiology.
34:912-917.
1996
|
|
| 1996
|
Acyclovir with and without Prednisone for the Treatment of Herpes Zoster: A Randomized, Placebo-Controlled Trial.
ACP journal club.
125:376-383.
1996
|
|
| 1996
|
Fluconazole therapy for histoplasmosis.
Clinical Infectious Diseases.
23:996-1001.
1996
|
|
| 1996
|
Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States.
Journal of Clinical Microbiology.
34:912-917.
1996
|
|
| 1996
|
Therapeutic efficacy and complications of excisional biopsy of condyloma acuminatum.
Sexually Transmitted Diseases.
23:273-276.
1996
|
|
| 1996
|
Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole.
Clinical Infectious Diseases.
22:46-50.
1996
|
|
| 1995
|
Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group..
Clinical Infectious Diseases.
21:994-996.
1995
|
|
| 1995
|
Alopecia associated with fluconazole therapy.
ACP journal club.
123:354-357.
1995
|
|
| 1995
|
Azithromycin for Empirical Treatment of the Nongonococcal Urethritis Syndrome in Men: A Randomized Double-blind Study.
Journal of the American Medical Association.
274:545-549.
1995
|
|
| 1995
|
Treatment of blastomycosis with fluconazole: a pilot study. The National Institute of Allergy and Infectious Diseases Mycoses Study Group..
Clinical Infectious Diseases.
20:267-271.
1995
|
|
| 1995
|
A randomized, double-blind, placebo-controlled trial of systemically administered interferon-α, -β, or -γ in combination with cryotherapy for the treatment of condyloma acuminatum.
Journal of Infectious Diseases.
171:1081-1089.
1995
|
|
| 1995
|
Comparison of multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for molecular subtyping of Cryptococcus neoformans.
Journal of Clinical Microbiology.
33:1890-1895.
1995
|
|
| 1995
|
Detection of specific antibodies in human blastomycosis by enzyme immunoassay.
Southern Medical Journal.
88:1256-1259.
1995
|
|
| 1995
|
Intravascular catheter exchange and duration of candidemia.
Clinical Infectious Diseases.
21:994-996.
1995
|
|
| 1995
|
Itraconazole for the treatment of histoplasmosis and blastomycosis.
International Journal of Antimicrobial Agents.
5:219-225.
1995
|
|
| 1995
|
Treatment of blastomycosis with fluconazole: A pilot study.
Clinical Infectious Diseases.
20:267-271.
1995
|
|
| 1994
|
A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia.
New England Journal of Medicine.
331:1325-1330.
1994
|
|
| 1994
|
Comparative analysis of three antifungal susceptibility test methods against prospectively collected Candida species.
Diagnostic Microbiology and Infectious Disease.
18:89-94.
1994
|
|
| 1994
|
Erratum: NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis (American Journal of Medicine (August 1994) 97 (135-144)).
American Journal of Medicine.
97:497.
1994
|
|
| 1994
|
Intraocular blastomycosis: Case report and review.
Clinical Infectious Diseases.
18:805-807.
1994
|
|
| 1994
|
NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis.
American Journal of Medicine.
97:135-144.
1994
|
|
| 1994
|
Pulmonary infection due to legionella cincinnatiensis in renal transplant recipients: Two cases and implications for laboratory diagnosis.
Clinical Infectious Diseases.
18:385-389.
1994
|
|
| 1993
|
Blastomycosis in immunocompromised patients.
Medicine.
72:311-325.
1993
|
|
| 1993
|
Penile Intraepithelial Neoplasia: Clinical Presentation and an Analysis of the Physical State of Human Papillomavirus DNA.
Journal of Infectious Diseases.
168:38-46.
1993
|
|
| 1993
|
SYPHILIS 100 YEARS AGO: PARALLELS WITH THE AIDS PANDEMIC.
International Journal of Dermatology.
32:708-709.
1993
|
|
| 1993
|
Unusual causes of pneumonia. Problems with diagnosis and management.
Immunology and Allergy Clinics of North America.
13:77-92.
1993
|
|
| 1992
|
Blastomycosis in patients with the acquired immunodeficiency syndrome.
ACP journal club.
116:847-853.
1992
|
|
| 1992
|
Human infection by genetically diverse SIVSM-related HIV-2 in West Africa.
Nature.
358:495-499.
1992
|
|
| 1991
|
Laboratory in the diagnosis and management of urinary tract infections.
Medical Clinics of North America.
75:313-325.
1991
|
|
| 1990
|
Chronic undifferentiated fever.
Current Opinion in Infectious Diseases.
3:632-637.
1990
|
|
| 1989
|
Gonococcal wound infection.
Southern Medical Journal.
82:1194.
1989
|
|
| 1989
|
Laser-induced nuclear orientation studies of 1-μs 85mRb.
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.
45:63-73.
1989
|
|
| 1989
|
Strategic defense initiative six years later in the army.
Journal of Aerospace Engineering.
2:111-118.
1989
|
|
| 1988
|
Kawasaki Syndrome Clusters in Harris County, Texas, and Eastern North Carolina: A High Endemic Rate and a New Environmental Risk Factor.
JAMA Pediatrics.
142:441-444.
1988
|
|
| 1986
|
Complete Doppler coverage in laser optical pumping by wall-induced velocity-changing collisions.
Physical Review A.
34:2477-2479.
1986
|
|
| 1986
|
Optical pumping to the 6s5d states in atomic barium.
Physical Review A.
33:2798-2800.
1986
|
|
| 1984
|
Laser-induced nuclear orientation of 1-s Rbm85.
Physical Review Letters.
53:2230-2233.
1984
|
|
| 1982
|
The effects of ultra-violet laser radiation on cancer.
Acupuncture and Electro-Therapeutics Research.
7:27-38.
1982
|
|
| 1981
|
Nuclear structure study of24mNa using laser induced nuclear orientation.
Hyperfine Interactions.
9:187-192.
1981
|
|
| 1981
|
Polarized sodium nuclei produced by laser optical pumping with velocity changing collisions.
Physical Review Letters.
47:236-239.
1981
|
|
| 1980
|
Laser-saturation spectroscopy with optical pumping.
Optics Letters.
5:79-81.
1980
|
|
| 1980
|
Saturation spectroscopy with laser optical pumping in atomic barium.
Physical Review A.
21:1955-1968.
1980
|
|
| 1979
|
Magnetic moment of 24mNa
1979
|
|
| 1979
|
LASER SATURATION SPECTROSCOPY WITH OPTICAL PUMPING..
Springer Series in Optical Sciences.
21:195-202.
1979
|
|
| 1978
|
Laser induced nuclear orientation: Intersection of laser and nuclear spectroscopy.
Hyperfine Interactions.
4:50-60.
1978
|
|
| 1977
|
Laser induced nuclear orientation effects.
Nuclear Instruments and Methods.
141:429-432.
1977
|
|
